December 16
QLT Announces Interim Results of RADICAL Study Evaluating Visudyne® Combination Therapy
PDF version
December 05
QLT Announces Commencement of Tender Offer
December 01
QLT To Repurchase Up to US$50 Million of Common Shares
October 28
QLT Announces Encouraging Phase II Data From Core Study of Punctal Plug Drug Delivery System
QLT Announces Third Quarter Results for 2008
October 20
QLT Announces Third Quarter 2008 Visudyne® Sales
October 09
QLT Announces the Initiation of a Phase I Trial of its Synthetic Retinoid Product
September 15
QLT Announces Completion of the Redemption of 3% Convertible Senior Notes Due 2023
September 02
QLT Completes CDN$65.5 Million Real Estate Transaction
August 26
QLT Announces Agreement to Exclusively License the Atrigel® Technology to Reckitt Benckiser Pharmaceuticals Inc.
August 11
QLT Announces Redemption of 3% Convertible Senior Notes Due 2023
August 08
QLT Announces Removal of Conditions on CDN$65.5 Million Real Estate Transaction
July 29
QLT Announces Second Quarter Results for 2008
July 17
QLT Announces Second Quarter 2008 Visudyne® Sales
July 14
QLT Completes Divestment of Aczone® to Allergan for USD$150 Million
June 09
QLT Announces Agreement to Sell Aczone® to Allergan for Approximately US$150 Million
June 06
QLT Announces Positive Health Canada Decision on Aczone®
May 15
QLT Inc. Announces Agreement for Sale of Real Estate
May 12
QLT Reports Initial Proof-of-Concept Data for Punctal Plug Delivery Technology
May 05
QLT Completes Enrollment in the RADICAL Study
April 25
QLT Announces First Quarter Results for 2008
April 21
QLT Announces First Quarter 2008 Visudyne® Sales
March 31
QLT Initiates Phase II Study of Punctal Plug Drug Delivery System for Glaucoma & Ocular Hypertension
March 28
Positive Results from Visudyne® Combination Therapy Study Reported at Annual Macula Society Conference
March 17
QLT Announces Positive FDA Action on Aczone™
February 21
QLT Announces 2007 Results
January 18
QLT Reduces Workforce as First Step in its Strategic Restructure
January 17
QLT Announces Visudyne® Sales for Fourth Quarter and Fiscal Year 2007
January 16
QLT Inc. Announces Initial Steps in Strategic Restructuring
